Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:1850909.
doi: 10.1155/2017/1850909. Epub 2017 Jan 31.

Optimizing Neuropsychological Assessments for Cognitive, Behavioral, and Functional Impairment Classification: A Machine Learning Study

Affiliations

Optimizing Neuropsychological Assessments for Cognitive, Behavioral, and Functional Impairment Classification: A Machine Learning Study

Petronilla Battista et al. Behav Neurol. 2017.

Abstract

Subjects with Alzheimer's disease (AD) show loss of cognitive functions and change in behavioral and functional state affecting the quality of their daily life and that of their families and caregivers. A neuropsychological assessment plays a crucial role in detecting such changes from normal conditions. However, despite the existence of clinical measures that are used to classify and diagnose AD, a large amount of subjectivity continues to exist. Our aim was to assess the potential of machine learning in quantifying this process and optimizing or even reducing the amount of neuropsychological tests used to classify AD patients, also at an early stage of impairment. We investigated the role of twelve state-of-the-art neuropsychological tests in the automatic classification of subjects with none, mild, or severe impairment as measured by the clinical dementia rating (CDR). Data were obtained from the ADNI database. In the groups of measures used as features, we included measures of both cognitive domains and subdomains. Our findings show that some tests are more frequently best predictors for the automatic classification, namely, LM, ADAS-Cog, AVLT, and FAQ, with a major role of the ADAS-Cog measures of delayed and immediate memory and the FAQ measure of financial competency.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests regarding the publication of this paper.

Figures

Figure 1
Figure 1
Representative example for one round and one iteration (CDR = 1 versus CDR = 0, round #1, iteration #1) of features ordered according to their FDR.
Figure 2
Figure 2
Features ordered according to their individual classification accuracy for CDR = 1 versus CDR = 0 (a), CDR = 0.5 versus CDR = 0 (b), and CDR = 1 versus CDR = 0.5 (c), using the feature reduction guided by the neuropsychologists. Results were obtained as average across all rounds (10) and iterations (100) but for each feature independently. Features are ranked in descending significance with respect to accuracy.
Figure 3
Figure 3
Highest accuracy of classification as a function of the configuration (combination of input features) in the inner loop of the nested CV. Performances are reported for CDR = 1 versus CDR = 0 (blue), CDR = 0.5 versus CDR = 0 (red), and CDR = 1 versus CDR = 0.5 (green), using the features chosen by the neuropsychologists. Results were obtained as average across all rounds (10) and iterations (100).

References

    1. Prince M., Bryce R., Albanese E., Wimo A., Ribeiro W., Ferri C. P. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & Dementia. 2013;9(1):63–75. doi: 10.1016/j.jalz.2012.11.007. - DOI - PubMed
    1. Querfurth H. W., LaFerla F. M. Alzheimer's disease. New England Journal of Medicine. 2010;362(4):329–344. doi: 10.1056/NEJMra0909142. - DOI - PubMed
    1. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Association; 2013.
    1. Lezak M. D., Howieson D. B., Loring D. W., Hannay H. J., Fischer J. S. Neuropsychological Assessment. 4th 2004.
    1. Fichman H. C., Oliveira R. M., Fernandes C. S. Neuropsychological and neurobiological markers of the preclinical stage of alzheimer's disease. Psychology and Neuroscience. 2011;4(2):245–253. doi: 10.3922/j.psns.2011.2.010. - DOI